These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

220 related items for PubMed ID: 10807653

  • 1. Caspase inhibition and limitation of myocardial infarct size: protection against lethal reperfusion injury.
    Mocanu MM, Baxter GF, Yellon DM.
    Br J Pharmacol; 2000 May; 130(2):197-200. PubMed ID: 10807653
    [Abstract] [Full Text] [Related]

  • 2. Non-specific caspase inhibition reduces infarct size and improves post-ischaemic recovery in isolated ischaemic/reperfused rat hearts.
    Kovacs P, Bak I, Szendrei L, Vecsernyes M, Varga E, Blasig IE, Tosaki A.
    Naunyn Schmiedebergs Arch Pharmacol; 2001 Dec; 364(6):501-7. PubMed ID: 11770004
    [Abstract] [Full Text] [Related]

  • 3. Protective effects of caspase-9 and poly(ADP-ribose) polymerase inhibitors on ischemia-reperfusion-induced myocardial injury.
    Sodhi RK, Singh M, Singh N, Jaggi AS.
    Arch Pharm Res; 2009 Jul; 32(7):1037-43. PubMed ID: 19641885
    [Abstract] [Full Text] [Related]

  • 4. Caspase inhibitor zVAD.fmk reduces infarct size after myocardial ischaemia and reperfusion in rats but not in mice.
    Mersmann J, Zacharowski PA, Schmitz I, Zacharowski K.
    Resuscitation; 2008 Dec; 79(3):468-74. PubMed ID: 18805622
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Doxorubicin treatment activates a Z-VAD-sensitive caspase, which causes deltapsim loss, caspase-9 activity, and apoptosis in Jurkat cells.
    Gamen S, Anel A, Pérez-Galán P, Lasierra P, Johnson D, Piñeiro A, Naval J.
    Exp Cell Res; 2000 Jul 10; 258(1):223-35. PubMed ID: 10912804
    [Abstract] [Full Text] [Related]

  • 7. B-type natriuretic peptide at early reperfusion limits infarct size in the rat isolated heart.
    Burley DS, Baxter GF.
    Basic Res Cardiol; 2007 Nov 10; 102(6):529-41. PubMed ID: 17896117
    [Abstract] [Full Text] [Related]

  • 8. Synergistic protective effect of caspase inhibitors and bFGF against brain injury induced by transient focal ischaemia.
    Ma J, Qiu J, Hirt L, Dalkara T, Moskowitz MA.
    Br J Pharmacol; 2001 Jun 10; 133(3):345-50. PubMed ID: 11375250
    [Abstract] [Full Text] [Related]

  • 9. In vivo myocardial infarct size reduction by a caspase inhibitor administered after the onset of ischemia.
    Huang JQ, Radinovic S, Rezaiefar P, Black SC.
    Eur J Pharmacol; 2000 Aug 18; 402(1-2):139-42. PubMed ID: 10940367
    [Abstract] [Full Text] [Related]

  • 10. Attenuation of increased myocardial ischaemia-reperfusion injury conferred by hypercholesterolaemia through pharmacological inhibition of the caspase-1 cascade.
    Wang TD, Chen WJ, Mau TJ, Lin JW, Lin WW, Lee YT.
    Br J Pharmacol; 2003 Jan 18; 138(2):291-300. PubMed ID: 12540519
    [Abstract] [Full Text] [Related]

  • 11. Inhibitors directed towards caspase-1 and -3 are less effective than pan caspase inhibition in preventing renal proximal tubular cell apoptosis.
    Yang B, El Nahas AM, Fisher M, Wagner B, Huang L, Storie I, Barnett D, Barratt J, Smith AC, Johnson TS.
    Nephron Exp Nephrol; 2004 Jan 18; 96(2):e39-51. PubMed ID: 14988591
    [Abstract] [Full Text] [Related]

  • 12. The neuroprotective effects of z-DEVD.fmk, a caspase-3 inhibitor, on traumatic spinal cord injury in rats.
    Barut S, Unlü YA, Karaoğlan A, Tunçdemir M, Dağistanli FK, Oztürk M, Colak A.
    Surg Neurol; 2005 Sep 18; 64(3):213-20; discussion 220. PubMed ID: 16099247
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Adiponectin protects against myocardial ischaemia-reperfusion injury via AMP-activated protein kinase, Akt, and nitric oxide.
    Gonon AT, Widegren U, Bulhak A, Salehzadeh F, Persson J, Sjöquist PO, Pernow J.
    Cardiovasc Res; 2008 Apr 01; 78(1):116-22. PubMed ID: 18222959
    [Abstract] [Full Text] [Related]

  • 15. Differential effects of caspase inhibitors on TNF-induced necroptosis.
    Sawai H.
    Biochem Biophys Res Commun; 2013 Mar 15; 432(3):451-5. PubMed ID: 23410748
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Differential effects of caspase inhibitors on endotoxin-induced myocardial dysfunction and heart apoptosis.
    Fauvel H, Marchetti P, Chopin C, Formstecher P, Nevière R.
    Am J Physiol Heart Circ Physiol; 2001 Apr 15; 280(4):H1608-14. PubMed ID: 11247771
    [Abstract] [Full Text] [Related]

  • 18. Caspase inhibition protects from liver injury following ischemia and reperfusion in rats.
    Cursio R, Gugenheim J, Ricci JE, Crenesse D, Rostagno P, Maulon L, Saint-Paul MC, Ferrua B, Mouiel J, Auberger P.
    Transpl Int; 2000 Apr 15; 13 Suppl 1():S568-72. PubMed ID: 11112076
    [Abstract] [Full Text] [Related]

  • 19. Combination of necroptosis and apoptosis inhibition enhances cardioprotection against myocardial ischemia-reperfusion injury.
    Koshinuma S, Miyamae M, Kaneda K, Kotani J, Figueredo VM.
    J Anesth; 2014 Apr 15; 28(2):235-41. PubMed ID: 24113863
    [Abstract] [Full Text] [Related]

  • 20. The caspase 9 inhibitor Z-LEHD-FMK protects human liver cells while permitting death of cancer cells exposed to tumor necrosis factor-related apoptosis-inducing ligand.
    Ozoren N, Kim K, Burns TF, Dicker DT, Moscioni AD, El-Deiry WS.
    Cancer Res; 2000 Nov 15; 60(22):6259-65. PubMed ID: 11103780
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.